小鼠抗TICAM1单克隆抗体100 UL上海生物网D198749
¥2000.00
小鼠抗PARG单克隆抗体100 UL上海生物网D198107
¥2000.00
小鼠抗APOBR单克隆抗体100 UL上海生物网D198327
¥2000.00
小鼠抗MKI67单克隆抗体100 UL上海生物网D198755
¥2000.00
1X TBS 脱脂奶粉粉末1 PK上海生物网C508104
¥121.00
技术规格
| Background: | This gene encodes a potent cyclin-dependent kinase inhibitor. The encoded protein binds to and inhibits the activity of cyclin-cyclin-dependent kinase2 or -cyclin-dependent kinase4 complexes, and thus functions as a regulator of cell cycle progression at G1. The expression of this gene is tightly controlled by the tumor suppressor protein p53, through which this protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. This protein can interact with proliferating cell nuclear antigen, a DNA polymerase accessory factor, and plays a regulatory role in S phase DNA replication and DNA damage repair. This protein was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of cyclin-dependent kinase2, and may be instrumental in the execution of apoptosis following caspase activation. Mice that lack this gene have the ability to regenerate damaged or missing tissue. Multiple alternatively spliced variants have been found for this gene. [provided by RefSeq, Sep 2015] |
| Applications: | WB, IHC |
| Name of antibody: | CDKN1A |
| Immunogen: | Fusion protein of human CDKN1A |
| Full name: | cyclin dependent kinase inhibitor 1A |
| Synonyms: | P21; CIP1; SDI1; WAF1; CAP20; CDKN1; MDA-6; p21CIP1 |
| SwissProt: | P38936 |
| IHC positive control: | carcinoma of human thyroid tissue |
| IHC Recommend dilution: | 30-150 |
| WB Predicted band size: | 18 kDa |
| WB Positive control: | HepG2 and MDCK cell lysates |
| WB Recommended dilution: | 200-1000 |
在线问
